. . . . . . . . . . . "p(HGNC:NRP2) -> bp(GO:angiogenesis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Osteosarcomas with NRP2 showed significantly poorer prognosis than those without NRP2. NRP acts as a VEGF-amplifier in a paracrine or autocrine manner in the osteosarcoma. NRP2 expression cooperatively promotes angiogenesis and growth in osteosarcomas with VEGF expression." . . "Selventa" . . . . "2014-07-03T14:29:51.615+02:00"^^ . . .